659 related articles for article (PubMed ID: 20138935)
21. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
22. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
23. Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles.
Rahmat D; Müller C; Barthelmes J; Shahnaz G; Martien R; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Feb; 83(2):149-55. PubMed ID: 23148989
[TBL] [Abstract][Full Text] [Related]
24. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
26. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
28. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
29. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties.
Rahmat D; Müller C; Shahnaz G; Leithner K; Laffleur F; Khan MI; Martien R; Bernkop Schnürch A
Drug Dev Ind Pharm; 2013 Sep; 39(9):1338-45. PubMed ID: 22901004
[TBL] [Abstract][Full Text] [Related]
30. Development and in vivo evaluation of papain-functionalized nanoparticles.
Müller C; Perera G; König V; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2014 May; 87(1):125-31. PubMed ID: 24373995
[TBL] [Abstract][Full Text] [Related]
31. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
32. Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Gibin S; Caramella C
Eur J Pharm Sci; 2008 Feb; 33(2):166-76. PubMed ID: 18248966
[TBL] [Abstract][Full Text] [Related]
33. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
[TBL] [Abstract][Full Text] [Related]
34. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
35. Design and in vivo evaluation of a patch system based on thiolated polymers.
Hoyer H; Greindl M; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):620-7. PubMed ID: 18661531
[TBL] [Abstract][Full Text] [Related]
36. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
37. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
[TBL] [Abstract][Full Text] [Related]
38. Mucus permeating thiomer nanoparticles.
Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
[TBL] [Abstract][Full Text] [Related]
39. An in-vitro exploration of permeation enhancement by novel polysulfonate thiomers.
Mahmood A; Bonengel S; Laffleur F; Ijaz M; Leonaviciute G; Bernkop-Schnürch A
Int J Pharm; 2015 Dec; 496(2):304-13. PubMed ID: 26453783
[TBL] [Abstract][Full Text] [Related]
40. Acidosis induces hyperpermeability in Caco-2BBe cultured intestinal epithelial monolayers.
Menconi MJ; Salzman AL; Unno N; Ezzell RM; Casey DM; Brown DA; Tsuji Y; Fink MP
Am J Physiol; 1997 May; 272(5 Pt 1):G1007-21. PubMed ID: 9176208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
